MedPath

Comparing Ondansetron and Ginger for the treatment of nausea and vomiting in pregnancy

Phase 3
Recruiting
Conditions
ausea and vomiting in pregnancy.
O21.0 Mild hyperemesis gravidarum
O21.0
Registration Number
IRCT20210303050564N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
150
Inclusion Criteria

Gestational age 6-16 weeks
Mild to moderate nausea and vomiting
Single pregnancy

Exclusion Criteria

Known underlying disease
Risk of pregnancy
Take anticoagulants
Known insensitivity to ginger and ondansetron

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The severity of nausea and vomiting. Timepoint: Measure the severity of nausea and vomiting at the beginning of the study and daily during treatment. Method of measurement: Rhodes Questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath